CSBR vs MMC · P/E 16, rev $56.9M vs P/E 22, rev $24.46B
Champions Oncology Inc (CSBR) versus Marsh & McLennan Companies Inc (MMC) — a side-by-side from cached financials, not a winner call.
Champions Oncology Inc (CSBR) is a biotechnology company listed on US.
Marsh & McLennan Companies Inc (MMC) is a insurance brokers company listed on US.
Latest reported CSBR revenue for 2025-04-30 was $56.9M. Net income was $4.7M. CSBR currently screens at market cap $99.8M and trailing P/E 16.0.
Latest reported MMC revenue for 2024-12-31 was $24.46B. Net income was $4.12B. MMC currently screens at market cap $89.82B and trailing P/E 21.9.
CSBR currently screens at market cap $99.8M and trailing P/E 16.0. MMC currently screens at market cap $89.82B and trailing P/E 21.9.
Not investment advice. Open the CSBR and MMC stock pages for the full models.
Not investment advice.